Epidemiology of adenovirus type 5 neutralizing antibodies in healthy people and AIDS patients in Guangzhou, southern China.
about
Neutralizing antibody responses to enterovirus and adenovirus in healthy adults in ChinaComparison of two high-throughput assays for quantification of adenovirus type 5 neutralizing antibodies in a population of donors in China.The sero-prevalence of anti-adenovirus 5 neutralizing antibodies is independent of a chronic hepatitis B carrier state in ChinaHuman adenovirus-specific γ/δ and CD8+ T cells generated by T-cell receptor transfection to treat adenovirus infection after allogeneic stem cell transplantation.Protection of adenovirus from neutralizing antibody by cationic PEG derivative ionically linked to adenovirusTwo adenovirus serotype 3 outbreaks associated with febrile respiratory disease and pharyngoconjunctival fever in children under 15 years of age in Hangzhou, China, during 2011.Circumventing antivector immunity by using adenovirus-infected blood cells for repeated application of adenovirus-vectored vaccines: proof of concept in rhesus macaques.A serological survey of human adenovirus serotype 2 and 5 circulating pediatric populations in Changchun, China, 2011Safety profile of gutless adenovirus vectors delivered into the normal brain parenchyma: implications for a glioma phase 1 clinical trialMucosal priming with a replicating-vaccinia virus-based vaccine elicits protective immunity to simian immunodeficiency virus challenge in rhesus monkeys.Development of an Ad5H3 Chimera Using the "Antigen Capsid-Incorporation" Strategy for an Alternative Vaccination Approach.Intramuscular delivery of adenovirus serotype 5 vector expressing humanized protective antigen induces rapid protection against anthrax that may bypass intranasally originated preexisting adenovirus immunity.The prevalence of neutralising antibodies to chimpanzee adenovirus type 6 and type 7 in healthy adult volunteers, patients with chronic hepatitis B and patients with primary hepatocellular carcinoma in China.Seroprevalence of neutralizing antibodies to human adenovirus type 5 in healthy adults in China.Seroprevalence of neutralizing antibodies against adenovirus type 14 and 55 in healthy adults in Southern China.Vaccine Engineering with Dual-Functional Mineral Shell: A Promising Strategy to Overcome Preexisting Immunity.Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver.Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults.Evaluation of monocytes as carriers for armed oncolytic adenoviruses in murine and Syrian hamster models of cancer.An adenovirus serotype 2-vectored ebolavirus vaccine generates robust antibody and cell-mediated immune responses in mice and rhesus macaques.Antibodies against adenovirus fiber and penton base proteins inhibit adenovirus vector-mediated transduction in the liver following systemic administration
P2860
Q33733003-2EC1CA69-A117-4BEF-AF19-6D4470B89FAAQ34289005-746F64C5-6A8C-4CB0-8A6E-F72605FA7AD5Q35204923-9B2D15FF-979E-43C7-96FD-B076CDA5BFF2Q35308252-0CDA29A4-0219-4526-95E7-D7CDDC943663Q35821087-E4F85FDD-47E8-4CA5-8BE7-2F00CDBBAEBDQ36022860-0450A292-34E5-41B7-AF65-59256E4ABB38Q36276187-4353D0D8-0F85-40B1-B0C3-7B27EE2B1A94Q36448142-38FC02EE-E680-4632-AF3F-D820CBDA06D6Q36534329-88E2AE9F-CC4A-459C-B5BB-AE0B56848190Q36827361-27C7AC9D-5773-4CB2-8019-C07BC9145922Q36966327-254A6831-69D7-4D58-8C3E-52E79EBA2AF5Q37545021-A16D5096-508E-4DD7-AA86-F4AD1EB95431Q39346309-B58316AA-089A-43A4-9ED6-74CC8A39BA7DQ39581144-11F959F5-46EB-432B-A0CA-EA85179ED51EQ40170219-2C9C913B-65D0-44C0-8FE9-03CD510D40D5Q41097174-B7AFE237-FC89-42CF-A526-A1E478D8264DQ42223027-089EB168-DE77-4E29-A623-9C84F0840C4AQ42266669-B813753F-48AB-4E4C-96F0-DB36A7FC9745Q42412637-5809E20F-A34E-4FD3-9456-1ECA1243869DQ55010162-CB9730C2-14E7-4CDE-A9B5-0E2E4F994489Q58770917-C509852C-BCD2-4FAD-95B6-47F9890BCFAD
P2860
Epidemiology of adenovirus type 5 neutralizing antibodies in healthy people and AIDS patients in Guangzhou, southern China.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Epidemiology of adenovirus typ ...... in Guangzhou, southern China.
@en
Epidemiology of adenovirus typ ...... in Guangzhou, southern China.
@nl
type
label
Epidemiology of adenovirus typ ...... in Guangzhou, southern China.
@en
Epidemiology of adenovirus typ ...... in Guangzhou, southern China.
@nl
prefLabel
Epidemiology of adenovirus typ ...... in Guangzhou, southern China.
@en
Epidemiology of adenovirus typ ...... in Guangzhou, southern China.
@nl
P2093
P921
P1433
P1476
Epidemiology of adenovirus typ ...... in Guangzhou, southern China.
@en
P2093
Caijun Sun
Liqiang Feng
Maochao Zhang
Xiaoping Chen
Zheyu Hong
P304
P356
10.1016/J.VACCINE.2011.03.042
P407
P577
2011-03-27T00:00:00Z